Systemic immune-inflammation index predicts prognosis in patients with different EGFR-mutant lung adenocarcinoma

Lung cancer is the most common type of cancer worldwide with a high mortality rate. The specific tyrosine kinase inhibitors of epidermal growth factor receptor (EGFR) have made enormous strides in non-small-cell lung cancer (NSCLC) treatment. The novel systemic immune-inflammation index (SII), a par...

Descripción completa

Detalles Bibliográficos
Autores principales: Ju, Qing, Huang, Tingping, Zhang, Yong, Wu, Lei, Geng, Jing, Mu, Xiaoyan, Yan, Tao, Zhang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886494/
https://www.ncbi.nlm.nih.gov/pubmed/33578585
http://dx.doi.org/10.1097/MD.0000000000024640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886494/
https://www.ncbi.nlm.nih.gov/pubmed/33578585
http://dx.doi.org/10.1097/MD.0000000000024640

Ejemplares similares